![Theresa Heah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theresa Heah
Directeur/Membre du Conseil chez
CURATIVE BIOTECHNOLOGY, INC.
Profil
Theresa G.
H.
Heah is the founder of Eyexora Global, Inc. Current jobs include Independent Director at Curative Biotechnology, Inc. since 2024; Member of The Royal College of Surgeons of Edinburgh; Member of the Royal College of Ophthalmologists; and Venture Partner at both Mitsui & Co. Global Investment, Inc. and Mitsui & Co. Global Investment Ltd. Former jobs include President & Chief Executive Officer at Intergalactic Therapeutics, Inc., Chief Executive Officer & Director at Paratus Sciences Corp., Vice President-Clinical Research & Medical Affairs at Aerie Pharmaceuticals, Inc., Chief Medical Officer at Beacon Therapeutics (USA), Inc. in 2019, and Chief Medical Officer & EVP-Operations at AsclepiX Therapeutics LLC.
Education includes an MBA from European School of Management & Technology GmbH and a doctorate from King's College London.
Postes actifs de Theresa Heah
| Sociétés | Poste | Début |
|---|---|---|
| CURATIVE BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 31/03/2024 |
Royal College of Ophthalmologists
 Royal College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Surgeons of Edinburgh
 The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Mitsui & Co. Global Investment, Inc.
 Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co Global Investment invests in companies located in the United States. The firm targets companies operating in the fields of health, technology, food and retail service sectors. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | - |
Mitsui & Co. Global Investment Ltd.
 Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Theresa Heah
| Sociétés | Poste | Fin |
|---|---|---|
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Directeur des opérations | 01/06/2021 |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Directeur Technique/Scientifique/R&D | 31/12/2019 |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur Général | - |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Develops novel non-viral gene therapies for patients | Directeur Général | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Theresa Heah
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Curative Biotechnology, Inc.
 Curative Biotechnology, Inc. Electronics DistributorsDistribution Services Operates as a biopharmaceutical company which develops therapeutics, medical devices and diagnostics | Distribution Services |
European School of Management & Technology GmbH
 European School of Management & Technology GmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Mitsui & Co. Global Investment, Inc.
Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co Global Investment invests in companies located in the United States. The firm targets companies operating in the fields of health, technology, food and retail service sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Finance |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Surgeons of Edinburgh
The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal College of Ophthalmologists
Royal College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Develops novel non-viral gene therapies for patients | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
